摘要
难治性肾病综合征是导致儿童终末期肾病的主要原因之一,也是临床治疗的棘手问题.近年来,新型免疫抑制剂,极大地改善了难治性肾病综合征患儿的预后.该文就近年来常用的免疫抑制剂环磷酰胺、环孢素、他克莫司、吗替麦考酚酯、来氟米特、利妥昔单抗等在不同类型的儿童难治性肾病综合征中的应用进展作一综述.
Refractory nephrotic syndrome (RNS) is one of the main causes of end-stage renal disease to children and also a difficult issue in clinic treatment. In recent years, the emergence of new irnmunosuppresive a- gents greatly improved the prognosis of children with RNS. In this paper, the application progress of immunosup- presive agents such as cyclophosphamide, ciclosporin, tacrolimus, mycophenolate mofetil, leflunomide and ritux- imab which were commonly used in recent years to different types of children with RNS are summarized.
出处
《国际儿科学杂志》
2014年第3期281-287,共7页
International Journal of Pediatrics
关键词
免疫抑制剂
儿童
难治性肾病综合征
Immunosuppressive agents
Children
Refractory nephritic syndrome